银屑病与特应性皮炎重叠表型的基因组分析
研究纳入41例临床诊断为银屑病或特应性皮炎(AD)的患者,重新分为经典银屑病(n=11)、经典AD(n=13)及重叠表型(n=17)。比较皮损与非皮损皮肤基因表达及血液蛋白质谱发现,重叠表型的全局mRNA表达、T细胞亚群细胞因子表达及血液蛋白标志物升高与银屑病一致,而与AD不同。无监督k-means聚类提示三组合计人群最佳聚类数为2,两聚类按基因表达可区分银屑病与AD。
要点
- 重叠表型皮肤的mRNA表达和T细胞细胞因子谱与银屑病一致、与AD不同。
- 重叠表型血液蛋白标志物升高模式与银屑病一致、与AD不同。
- 基因组生物标志物可在分子水平区分银屑病与AD。
核心结论
- 银屑病与AD临床重叠表型具有银屑病主导的分子特征。
- 基因组生物标志物可在分子水平区分银屑病与AD。
研究设计与样本
- 纳入41例诊断为银屑病或AD的患者,临床再分层为经典银屑病(n=11)、经典AD(n=13)和重叠表型(n=17)。
- 比较三组皮损与非皮损皮肤活检组织的基因表达谱及血液样本的蛋白质谱。
主要发现
- 重叠表型皮肤全局mRNA表达和T细胞亚群细胞因子表达与银屑病一致、与AD不同。
- 重叠表型血液蛋白生物标志物升高与银屑病一致、与AD不同。
- 无监督k-means聚类显示三组合计人群最佳聚类数为2,两聚类按基因表达区分银屑病与AD。
临床怎么用
- 临床重叠表型可考虑按银屑病进行分子层面的评估。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Clinical overlaps between psoriasis and atopic dermatitis (AD) are sometimes undiscernible, and there is no consensus on whether to treat the overlap phenotype as psoriasis or AD. We enrolled 41 patients diagnosed with either psoriasis or AD and clinically re-stratified them into classic psoriasis (n = 11), classic AD (n = 13), and the overlap phenotype between psoriasis and AD (n = 17). We compared the gene expression profiles of lesional and nonlesional skin biopsy tissues and the proteomic profiles of blood samples among the three comparison groups. Global mRNA expression and T-cell subset cytokine expression in the skin and protein biomarker elevation in the blood of the overlap phenotype were consistent with the profiles of psoriasis and different from the profiles of AD. Unsupervised k-means clustering indicated that the best number of distinct clusters for the total population of the three comparison groups was two, and the two clusters of psoriasis and AD were differentiated by gene expression. Our study suggests that the clinical overlap phenotype between psoriasis and AD has dominant molecular features of psoriasis, and genomic biomarkers can differentiate psoriasis and AD at molecular levels in patients with a spectrum of psoriasis and AD.
引用
- Kim JE, Lee J, Huh YJ, et al. Genomic Profiling of the Overlap Phenotype between Psoriasis and Atopic Dermatitis. J Invest Dermatol. 2023. PMID: 37419444. doi:10.1016/j.jid.2023.06.194
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。